Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine Antigens

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Infection and Immunity

• Publication date

  2000-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.68.10.5764-5770.2000PMID 10992483PMCID PMC101535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Immunology of influenza].

  2001cited by this paper
• Mucosal immunity and tolerance: relevance to vaccine development

  1999cited by this paper
• CpG motifs as immune adjuvants.

  1999cited by this paper
• Intranasal Immunization of Mice with Influenza Vaccine in Combination with the Adjuvant LT-R72 Induces Potent Mucosal and Serum Immunity Which Is Stronger than That with Traditional Intramuscular Immunization

  1999cited by this paper
• Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat‐labile enterotoxin

  1999cited by this paper
• The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice.

  1999cited by this paper
• Effect of chitosan on epithelial permeability and structure.

  1999cited by this paper
• Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat‐labile enterotoxin and its B subunit

  1998cited by this paper
• Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.

  1998cited by this paper
• Chitosan: a unique polysaccharide for drug delivery.

  1998cited by this paper
• Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine.

  1998cited by this paper
• In vitro degradation rates of partially N-acetylated chitosans in human serum.

  1997cited by this paper
• Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers.

  1997cited by this paper
• Chitin biotechnology applications.

  1996cited by this paper
• Chitosan as a nasal delivery system: evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models

  1996cited by this paper
• Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres

  1995cited by this paper
• A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins

  1995cited by this paper
• Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment.

  1995cited by this paper
• Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.

  1995influential reference
• Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies

  1995cited by this paper
• Chitosan as a nasal delivery system: Evaluation of the effect of chitosan on mucociliary clearance rate in the frog palate model

  1995cited by this paper
• Chitosan as a Novel Nasal Delivery System for Peptide Drugs

  1994cited by this paper
• Chitosan-mediated stimulation of macrophage function.

  1994cited by this paper
• Morphological and biochemical characterization of influenza vaccines commercially available in the United Kingdom.

  1994cited by this paper
• Molecular adjuvants and immunomodulators: new approaches to immunization

  1994cited by this paper
• Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)

  1994cited by this paper
• New strategies for using mucosal vaccination to achieve more effective immunization.

  1994cited by this paper
• Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine.

  1994cited by this paper
• Rheological properties of polymer solutions as carriers for nasal drug delivery systems

  1993cited by this paper
• Genetics and molecular biology of chitin synthesis in fungi.

  1993cited by this paper
• Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.

  1993cited by this paper
• Neutralization of influenza virus by low concentrations of hemagglutinin-specific polymeric immunoglobulin A inhibits viral fusion activity, but activation of the ribonucleoprotein is also inhibited

  1992cited by this paper
• Cross‐linked Chitosan Microspheres: Preparation and Evaluation as a Matrix for the Controlled Release of Pharmaceuticals

  1992cited by this paper
• Mucosal immunity: implications for vaccine development.

  1992cited by this paper
• In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers

  1992cited by this paper
• Local and systemic influenza haemagglutinin-specific antibody responses following aerosol and subcutaneous administration of inactivated split influenza vaccine.

  1992cited by this paper
• Passive transfer of local immunity to influenza virus infection by IgA antibody.

  1991cited by this paper
• Influenza immunization: intranasal live vaccinia recombinant contrasted with parenteral inactivated vaccine.

  1991cited by this paper
• The nasal delivery of peptides and proteins.

  1991cited by this paper
• Insights into neutralization of animal viruses gained from study of influenza virus

  1991cited by this paper
• Immunoglobulin A mediation of murine nasal anti-influenza virus immunity

  1991cited by this paper
• Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.

  1990cited by this paper
• Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates.

  1990cited by this paper
• Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit.

  1989cited by this paper
• Gelrite®: A novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol

  1989cited by this paper
• Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit.

  1988cited by this paper
• Chemical composition of the yeast ascospore wall. The second outer layer consists of chitosan.

  1988cited by this paper
• Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine

  1986cited by this paper
• Immunological Activity of Chitin Derivatives

  1986cited by this paper
• The immune response to influenza infection.

  1986influential reference
• The immunology of influenza.

  1985cited by this paper
• Immunological activity of chitin and its derivatives.

  1984cited by this paper
• Protecting Effect of Chitin and Chitosan on Experimentally Induced Murine Candidiasis

  1984cited by this paper
• Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

  1984cited by this paper
• Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus

  1983cited by this paper
• A COMPARATIVE EVALUATION OF LIQUID ANTACIDS COMMERCIALLY AVAILABLE IN THE UNITED KINGDOM

  1982cited by this paper
• THE BASIS FOR IMMUNITY TO INFLUENZA IN MAN

  1981cited by this paper
• Genetic variation among influenza viruses

  1981cited by this paper
• A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

  1978cited by this paper
• The Influenza Viruses and Influenza

  1976cited by this paper
• A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins

  1976cited by this paper
• Standardized viral hemagglutination and hemagglutination-inhibition tests. I. Standardization of erythrocyte suspensions.

  1969cited by this paper

• Revolutionizing Veterinary Vaccines: Overcoming Cold-Chain Barriers Through Thermostable and Novel Delivery Technologies

  2025cites this paper
• Next-generation subunit vaccine delivery systems: Design, applications, and prospects

  2024cites this paper
• Preparation and characterization of curdlan-chitosan conjugate nanoparticles as mucosal adjuvants for intranasal influenza H1N1 subunit vaccine.

  2024cites this paper
• NAVIGATING THE LANDSCAPE OF ADJUVANTS FOR SUBUNIT VACCINES: RECENT ADVANCES AND FUTURE PERSPECTIVES

  2024cites this paper
• A Novel Vision of Reinforcing Nanofibrous Masks with Metal Nanoparticles: Antiviral Mechanisms Investigation

  2023cites this paper
• Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines

  2023cites this paper
• Recent advances in respiratory immunization: A focus on COVID-19 vaccines

  2023cites this paper
• Managing Apoptosis in Lung Diseases Using Nano-Assisted Drug Delivery System.

  2022cites this paper
• Chitosan-based formulation of hemagglutinin antigens for oculo-nasal booster vaccination of chickens against influenza viruses.

  2022cites this paper
• The evolution of the global COVID-19 epidemic in Morocco and understanding the different therapeutic approaches of chitosan in the control of the pandemic

  2022cites this paper
• Chitin and chitosan as tools to combat COVID-19: A triple approach

  2021cites this paper
• Underscoring the immense potential of chitosan in fighting a wide spectrum of viruses: A plausible molecule against SARS-CoV-2?

  2021cites this paper
• Chemical Proprieties of Biopolymers (Chitin/Chitosan) and Their Synergic Effects with Endophytic Bacillus Species: Unlimited Applications in Agriculture

  2021influential citation
• Fluid gels: A systematic review towards their application in pharmaceutical dosage forms and drug delivery systems

  2021cites this paper
• Bioproduction of biomacromolecules for antiviral applications.

  2021cites this paper
• Intranasal vaccine: factors to consider in research and development.

  2021cites this paper
• Towards antiviral polymer composites to combat COVID‐19 transmission

  2021cites this paper
• REVIEW: Nanobiotechnology: Cradle for revolution in drug carrier systems.

  2021cites this paper
• Nanoparticles (PLGA and Chitosan)-Entrapped ADP-Ribosylation Factor 1 of Haemonchus contortus Enhances the Immune Responses in ICR Mice

  2020cites this paper
• Mucoadhesive Properties of Gellan and Its Modified Derivatives

  2020cites this paper
• Biopolymers and natural polymers

  2020cites this paper
• Engineered Nanoparticle Applications for Recombinant Influenza Vaccines.

  2020cites this paper
• Evaluation of the mucoadhesive strengths of Abelmoschus esculentus and Irvingia gabonensis gums for possible application in veterinary vaccine delivery: the effect of extraction methods

  2020cites this paper
• Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases

  2019cites this paper
• Carbohydrates in Vaccine Development.

  2019cites this paper
• Use of Biopolymers in Mucosally-Administered Vaccinations for Respiratory Disease

  2019influential citation
• Acute inflammation and influenza: Innovative nanoparticle vaccination studies in a pig model

  2019cites this paper
• Gellan gum in drug delivery applications

  2019cites this paper
• Polymers for subunit vaccine delivery

  2019cites this paper
• Thiolated γ-polyglutamic acid as a bioadhesive hydrogel-forming material: evaluation of gelation, bioadhesive properties and sustained release of KGF in the repair of injured corneas.

  2019cites this paper
• Application of Chitosan in Oral Drug Delivery

  2019cites this paper
• Immunology‐Guided Biomaterial Design for Mucosal Cancer Vaccines

  2019cites this paper
• Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections

  2019cites this paper
• Intranasal delivery of influenza antigen by nanoparticles, but not NKT-cell adjuvant differentially induces the expression of B-cell activation factors in mice and swine.

  2018cites this paper
• Physicochemical and immunological characterization of chitosan-coated bacteriophage nanoparticles for in vivo mycotoxin modeling.

  2018cites this paper
• Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs

  2018cites this paper
• Effects of chitosan as growth promoter on diarrhea, nutrient apparent digestibility, fecal microbiota and immune response in weaned piglets

  2018cites this paper
• Inactivated enterovirus 71 with poly-γ-glutamic acid/Chitosan nano particles (PC NPs) induces high cellular and humoral immune responses in BALB/c mice

  2018cites this paper
• Classification of Nanomaterials

  2017cites this paper
• BCG-loaded chitosan microparticles: interaction with macrophages and preliminary in vivo studies

  2017cites this paper
• Evaluation of Immunogenicity of Chitosan Nanoparticles Containing STxB and STxB-IpaD Antigens of Shigella Dysenteriae Type 1 in Mice

  2017cites this paper
• Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes.

  2017cites this paper
• Review Article Emerging Trends in Novel Drug Delivery System: Intra Nasal Drug Delivery

  2016cites this paper
• Vaccine Delivery: Current Routes of Administration and Novel Approaches

  2016cites this paper
• KİTOSAN VE ANTİMİKROBİYAL ÖZELLİKLERİ

  2016cites this paper
• Nasal-nanotechnology: revolution for efficient therapeutics delivery

  2016cites this paper
• Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs

  2016cites this paper
• Development of gellan gum fluid gel as modified release drug delivery systems

  2016cites this paper
• EPSAH, an exopolysaccharide from Aphanothece halophytica GR02, improves both cellular and humoral immunity as a novel polysaccharide adjuvant.

  2016cites this paper
• Evaluation of Immune Response Against Inactivated Avian Influenza (H9N2) Vaccine, by Using Chitosan Nanoparticles

  2015cites this paper
• Combinatorial Approach of Antigen Delivery Using M Cell-Homing Peptide and Mucoadhesive Vehicle to Enhance the Efficacy of Oral Vaccine.

  2015cites this paper
• Development of mucoadhesive sprayable gellan gum fluid gels.

  2015cites this paper
• Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation

  2015cites this paper
• Nanoparticles in Vaccine Development

  2015cites this paper
• CHITOSAN: A MULTIFACET POLYMER

  2015cites this paper
• Chitosan: An Emanating Polymeric Carrier for Drug Delivery

  2015cites this paper
• CHITOSAN: A MULTIFACET POLYMER Review Article

  2015cites this paper
• Polymeric Biomaterials for Controlled Drug Delivery

  2015cites this paper
• Handbook of Encapsulation and Controlled Release

  2015cites this paper
• Influenza vaccine immune preparation for nasal administration and preparation method thereof

  2015cites this paper
• Controlled Drug Delivery: Polymeric Biomaterials for

  2015cites this paper
• Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine

  2015cites this paper
• Towards an improved vaccination programme against highly pathogenic avian influenza in Indonesia

  2014cites this paper
• Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants.

  2014cites this paper
• Approaches to tuberculosis mucosal vaccine development using nanoparticles and microparticles: a review.

  2014cites this paper
• Heterologous expression and secretion of an antifungal Bacillus subtilis chitosanase (CSNV26) in Escherichia coli

  2013cites this paper
• DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases

  2013cites this paper
• Nanotechnology in the Treatment of Infectious Diseases

  2013cites this paper
• Biological Applications of Chitin, Chitosan, Oligosaccharides and Their Derivatives

  2013cites this paper
• A polysaccharide isolated from Agaricus blazei Murill (ABP-AW1) as a potential Th1 immunity-stimulating adjuvant

  2013cites this paper
• Nanotechnological Approaches for Genetic Immunization

  2013cites this paper
• Chitosan-based drug delivery systems.

  2012cites this paper
• The Mucosal Adjuvant Potential of Cross-Linked Dextran Microspheres as Dry Powder

  2012cites this paper
• Immune Responce in Mice Immunized with Live Cold-Adapted Influenza Vaccine in Combination with Chitosan-Based Adjuvants

  2012cites this paper
• CriticalSorb™: enabling systemic delivery of macromolecules via the nasal route

  2012cites this paper
• Chitosan-based delivery systems for mucosal vaccines

  2012cites this paper
• Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge

  2012cites this paper
• Induction of respiratory immune responses in the chicken; implications for development of mucosal avian influenza virus vaccines

  2012cites this paper
• Nasal drug delivery - recent developments and future prospects.

  2012cites this paper
• A review on mucoadhesive polymer used in nasal drug delivery system

  2011cites this paper
• A lack of antibody formation against inactivated influenza virus after aerosol vaccination in presence or absence of adjuvantia.

  2011cites this paper
• Vaccination of mice with chitosan nanogel‐associated recombinant NcPDI against challenge infection with Neospora caninum tachyzoites

  2011cites this paper
• The growing role of nanotechnology in combating infectious disease

  2011cites this paper
• The Eurocine L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination.

  2010cites this paper
• Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant

  2010cites this paper
• Chitosan can stop or postpone the death of the suckling mice challenged with foot-and-mouth disease virus

  2010cites this paper
• Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.

  2010cites this paper
• In situ gelling nasal inserts for influenza vaccine delivery

  2010cites this paper
• Nanotechnology solutions for mucosal immunization.

  2010cites this paper
• The application of mucoadhesive polymers in nasal drug delivery.

  2010cites this paper
• Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers

  2010cites this paper
• Bio-function Summary of Marine Oligosaccharides

  2010cites this paper
• The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine.

  2010cites this paper
• Comparison of Adjuvant Efficacy of Chitosan and Aluminum Hydroxide for Intraperitoneally Administered Inactivated Influenza H5N1 Vaccine

  2010cites this paper
• New Approaches to Vaccine Delivery

  2010cites this paper
• Preparation and in vivo study of dry powder microspheres for nasal immunization

  2010cites this paper
• Caractérisation et comparaison des propriétés immunostimulantes de nanoparticules biodégradables de poly(acide lactique) et de chitosane après adsorption de TLR ligands ou d’antigènes du VIH1

  2010cites this paper
• The application of mucoadhesive polymers in nasal drug delivery

  2010cites this paper
• Chitosan/Chitosan Derivatives as Carriers and Immunoadjuvants in Vaccine Delivery

  2010cites this paper
• Needle-free influenza vaccination.

  2010cites this paper